Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG2000 micelles
Gambogic acid
DOI:
10.2147/ijn.s54050
Publication Date:
2013-12-29T20:46:25Z
AUTHORS (11)
ABSTRACT
The clinical application of gambogic acid, a natural component with promising antitumor activity, is limited due to its extremely poor aqueous solubility, short half-life in blood, and severe systemic toxicity. To solve these problems, an amphiphilic polymer-drug conjugate was prepared by attachment low molecular weight (ie, 2 kDa) methoxy poly(ethylene glycol) methyl ether (mPEG) acid (GA-mPEG₂₀₀₀) through ester linkage characterized (1)H nuclear magnetic resonance. GA-mPEG₂₀₀₀ conjugates self-assembled form nanosized micelles, mean diameters less than 50 nm, very narrow particle size distribution. properties the including morphology, stability, modeling, drug release profile, were evaluated. MTT (3-(4,5-dimethylthiazo l-2-yl)-2,5 diphenyl tetrazolium bromide) tests demonstrated that micelle formulation had obvious cytotoxicity tumor cells human umbilical vein endothelial cells. Further, micelles effective inhibiting growth prolonged survival subcutaneous B16-F10 C26 models. Our findings suggest may have applications therapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....